Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 28 JUNE 2024

Pharmaceutical Industry & IPR In India: Balance Between Innovation & Access

Naik Naik & Company
Naik Naik & Company
Contributor
Naik Naik & Company

Naik Naik & Company

The firm Naik Naik & Co is a full-service law firm Headquartered in Mumbai with affiliate offices...

View firm profile
Explore more from Naik Naik & Company

The pharmaceutical industry involves not only manufacturing and distribution but drug discovery, Research & Development ("R&D"), planning, mapping and pricing of lifesaving medications.

IndiaIntellectual Property
Malabika Boruah
Malabika Boruah
Aishee Choudhury
Aishee Choudhury

The pharmaceutical industry involves not only manufacturing and distribution but drug discovery, Research & Development ("R&D"), planning, mapping and pricing of lifesaving medications. Intellectual property rights ("IPR") in pharma consist of patents, trademarks, copyright, trade designs and trade secrets, which help tremendously in getting these medicines on the market. The interface between the pharmaceutical industry and IPR helps innovators protect inventions and get exclusive trade monopolies and monetary rewards. India has emerged as a global leader in the production and export of generic medicines and lifesaving vaccines all over the world. The involvement of various IPR laws plays a crucial role in boosting growth and development in this field.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Copy, Right? ANI Media Pvt. Ltd. v. Open AI OpCo LLC

When an artificial intelligence system is trained on copyrighted news content, and later answers a user’s question using what it learned, has the law been broken? On 24th July 2026, the Delhi High Court answered that question, at least for now. In ANI Media Pvt. Ltd. v. Open AI OpCo LLC, Justice Amit Bansal declined to grant an interim injunction against OpenAI, holding, on a prima facie, interim stage view, that the company’s use of ANI’s news content to train its large language models (“LLMs”) falls within the fair dealing exception under Section 52(1)(a) of the Copyright Act, 1957
IndiaIntellectual Property
S.S. Rana & Co.
S.S. Rana & Co.
Article

AI Training Data, Copyright Risk And Commercial Liability: What Businesses Need To Know

On 8 October 2026, USA Today Co. and its affiliated newspaper companies, which publish 19 titles including USA Today, the Detroit Free Press and The Arizona Republic, sued seven OpenAI entities in the US District Court for the Southern District of New York. The complaint alleges that OpenAI copied their journalism to train its models, stripped identifying information from it, and now uses those models to give ChatGPT users summaries that substitute for the original reporting. The publishers seek more than USD 250 million in damages, an injunction and an order for the destruction of models and training sets containing their content.
IndiaIntellectual Property
Legitpro Law
Legitpro Law